A Phase I Study of BR108 in Hematological Malignancies

Clinical trial NCT06018506 · TERMINATED

Trial details

NCT number: NCT06018506
Sponsor: BioRay Pharmaceutical Co., Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Malignancy

Start date: 2023-03-18
Primary completion: 2024-05-27
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.